Naples Global Advisors LLC Sells 694 Shares of CVS Health Corporation $CVS

Naples Global Advisors LLC trimmed its position in CVS Health Corporation (NYSE:CVS) by 8.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,025 shares of the pharmacy operator’s stock after selling 694 shares during the period. Naples Global Advisors LLC’s holdings in CVS Health were worth $554,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. Bell Investment Advisors Inc grew its holdings in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC lifted its holdings in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC grew its stake in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the period. Saudi Central Bank bought a new stake in shares of CVS Health in the first quarter worth about $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the second quarter worth about $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.22% of the company’s stock.

CVS Health Price Performance

NYSE:CVS opened at $77.51 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $70.71 and a 200 day simple moving average of $67.34. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $79.20. The stock has a market capitalization of $98.31 billion, a PE ratio of 21.65, a P/E/G ratio of 0.85 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s payout ratio is presently 74.30%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Bernstein Bank lowered their target price on CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a research note on Wednesday, July 16th. Jefferies Financial Group raised their price objective on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Sanford C. Bernstein boosted their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Barclays boosted their price target on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $78.25.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.